+ Watch NVS
on My Watchlist
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
NVS has an enviable strategic position with a nice pipeline of late-stage products. Diversified product lines buffer the company from difficulties in any one segment. NVS also benefits from increased adoption of generic drugs. Steady, defensive big pharma play with a good margin of safety at current levels.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions